ロード中...
Exenatide Use in the Management of Type 2 Diabetes Mellitus
Exenatide is a GLP-1 (glucagon-like peptide-1) agonist that has been approved in the UK for use in the management of Type 2 Diabetes Mellitus (T2DM) since 2006. It acts by increasing glucose-induced insulin release and by reducing glucagon secretion postprandially. It therefore increases insulin sec...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4033938/ https://ncbi.nlm.nih.gov/pubmed/27713366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph3082554 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|